China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	18.51	12.07	17.37	15.52	13.33	7.29
Cash & Short-Term Investments	18.51	12.07	17.37	15.52	13.33	7.29
Cash Growth	61.47%	-30.50%	11.88%	16.43%	82.97%	-20.19%
Accounts Receivable	1.66	1.31	1.34	3.37	4.51	3.84
Other Receivables	-0.05	0.03	0.23	0.66	0.65	4.37
Receivables	1.61	1.35	1.58	5.53	6.66	9.7
Inventory	1.59	0.81	0.58	1.07	1.38	1.05
Restricted Cash	-	0.01	-	0.05	0.03	-
Other Current Assets	0.28	-	-	0.29	1.83	1.6
Total Current Assets	21.99	14.23	19.52	22.45	23.23	19.64
Property, Plant & Equipment	0.44	0.56	1.27	1.59	1.79	1.9
Other Intangible Assets	0.02	0.02	0.03	0.04	0.05	0.05
Long-Term Deferred Tax Assets	-	-	-	-	0.32	0.11
Other Long-Term Assets	8.55	8.31	8.74	9.46	9.16	-
Total Assets	31	23.13	29.55	33.55	34.55	21.7
Accounts Payable	1.66	1.28	1.38	1.48	1.46	1.94
Accrued Expenses	1.72	1.59	1.74	2.01	1.51	0.81
Short-Term Debt	9.53	3.32	8.53	10.73	12.15	-
Current Portion of Long-Term Debt	0.01	0.02	0.01	0.01	0.04	6.69
Current Portion of Leases	0.03	0.06	0.06	-	-	-
Current Income Taxes Payable	1.09	1.05	1.1	1.17	1.16	0.99
Current Unearned Revenue	0.19	0.19	0.17	-	-	-
Other Current Liabilities	1.42	1.39	1.52	1.72	2.26	1.84
Total Current Liabilities	15.66	8.9	14.5	17.12	18.58	12.26
Long-Term Debt	0.12	0.12	0.12	-	0.01	0.04
Long-Term Leases	0.18	0.18	0.25	-	-	-
Total Liabilities	15.96	9.2	14.86	17.12	18.59	12.3
Common Stock	7.73	4.35	0.91	0.16	0.06	0.03
Additional Paid-In Capital	33.39	35.32	35.59	30.99	25.32	17.16
Retained Earnings	-25.51	-24.71	-21.61	-15.69	-9.95	-7.2
Comprehensive Income & Other	-0.57	-1.03	-0.2	0.96	0.53	-0.59
Shareholders' Equity	15.03	13.93	14.69	16.42	15.96	9.4
Total Liabilities & Equity	31	23.13	29.55	33.55	34.55	21.7
Total Debt	9.87	3.7	8.96	10.74	12.19	6.72
Net Cash (Debt)	8.64	8.38	8.41	4.78	1.14	0.56
Net Cash Growth	9.47%	-0.39%	75.82%	319.07%	102.64%	-91.13%
Net Cash Per Share	30.96	77.24	251.95	-	-	-
Filing Date Shares Outstanding	0.49	0.43	0.07	0.01	-	-
Total Common Shares Outstanding	0.49	0.28	0.06	0.01	-	-
Working Capital	6.32	5.33	5.02	5.33	4.65	7.37
Book Value Per Share	30.79	50.24	256.97	1617.08	-	-
Tangible Book Value	15.02	13.91	14.66	16.39	15.92	9.35
Tangible Book Value Per Share	30.76	50.17	256.48	1613.27	-	-
Machinery	1.12	1.19	1.24	1.27	1.19	1.04
Construction In Progress	-	-	-	0.36	0.36	0.33
Leasehold Improvements	1.61	1.56	1.64	1.78	1.7	1.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q